NPA chairman Olivier Picard said ‘many more people are interested in getting weight loss jabs than would actually be suitable for treatment’.

The National Pharmacy Association (NPA) has issued a warning that the burgeoning demand for weight loss injections may be ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Experts have explained how one sign of dementia might appear while a person is walking. According to specialists, this ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Some people are worried about the possible side effect of 'food noise' after coming off Mounjaro. Also known as tirzepatide, the weight-loss drug is a prescription medication designed for patients ...

One person using Mounjaro revealed they had a peculiar ‘magic mushroom’ sensation when starting the medication in a discussion about side effects on Reddit ...

Rosie O'Donnell, who's been opening up about her weight-loss journey online, celebrated her progress in a new post.

Demand for Eli Lilly’s LLY blockbuster GLP-1 medicines — Mounjaro (for type II diabetes) and Zepbound (for obesity) — remains strong. Despite being on the market for less than three years ...

Mounjaro and Zepbound directly compete with Novo Nordisk’s semaglutide medicines, Ozempic for diabetes and Wegovy for obesity. Like Lilly, Novo also generates a substantial portion of revenues from ...

Mounjaro became available on the NHS for eligible patients on 23rd June 2025 as part of a phased rollout. With an initial aim of focusing on those with the greatest clinical needs, Mounjaro is ...